s of components, competition, the timing of regulatory approvals, the implementation, including any modification, of the Company's strategic operating plans, the uncerta'/>/>SOURCE Luminex CorporationCopyright??2010 PR Newswire.All rights reserved0GOODPage: 1 2 3 4 5 6 7 8 9 Related medicine technology :1.